This report, prepared by the RAND Corporation for the House of Commons Select Committee on Science and Technology in the United Kingdom, presents the results of four case studies examining the evidence base for the classification of illegal drugs in the context of the 1971 Misuse of Drugs Act.

This briefing paper looks at the history of the use of psychoactive drugs in India, and particularly the use of Cannabis and Opium derivatives in religious and social rituals.

Based on two studies carried out in the cities of Buenos Aires and Montevideo and additional research in Brazil, this report examines the origin, characteristics and impact of the explosive increase in consumption of cocaine base paste and crack in urban areas.

The third briefing paper from IDPC is a response to the call of the European Commission for civil society organisations to express their views on the Commission's Green Paper on the Role of Civil Society in Drugs Policy in the European Union.

Plan Colombia having run its course, the U.S. government's own data indicate that coca cultivation is expanding in Colombia, cocaine remains readily available in the United States, and cocaine use is steady, if not rising, including among youth.

This study investigated whether three measures of legal repressiveness in large US metropolitan areas were associated with the population prevalence of injection drug use and with HIV prevalence among IDUs.

Providing alternatives to drug crops is believed to be crucial to achieve effective eradication. The U.S. approach to alternative development is to link it to eradication.

This report does not offer predictions, but it does raise issues and possibilities that policy makers and others might wish to consider. Some are more speculative than others. As this report looks out to 2025 and future possibilities, it inevitably challenges current thinking.

This document focus on mechanisms through which police activities, occurring in drug markets, intersect with the health and practices of illicit drug users, the delivery of health care, and dynamics within neighbouring communities. The authors conclude with a discussion of the benefits and costs…

Finding that U.S. drug control policy has been only marginally successful in achieving national objectives, the Strategy Research Project will propose possible reasons for its ineffectiveness and recommend alternatives to improve policy.

This report aims to give policymakers an accessible summary of the current evidence available on the effectiveness of treatment, and suggestions on how treatment services can be expanded and integrated into a co-ordinated system.

The proceedings of the 8th European Conference on Drugs and Infections Prevention in Prison, "Unlocking Potential: Making Prisons Safe for Everyone” organised by Cranstoun Drug Services on behalf of the European Network on Drugs and Infections Prevention in Prison, at Corinthia Grand Hotel,…

The Thai 'war on drugs', which commenced in February 2003 in response to an explosion in methamphetamine use in this region of East Asia, has resulted in thousands of deaths and tens of thousands of arrests.

This paper looks at changing approaches to the drug problem in Iran where there is growing recognition of the limits of an enforcement driven approach, and the importance of the medical and social dimensions of drug misuse.

This report looks at the approach to drug policy that has dominated the field for much of the past 40 years, and is sometimes characterised - and, to some degree, caricatured - as the 'war on drugs' approach.

This report looks at the various ways in which the use of illegal drugs causes harm to individual and public health.

The International Narcotic Control Board (INCB) is a thirteen member body of independent experts charged with monitoring implementation of three international drug control treaties known as the UN conventions.

In July 2001, Portugal's government implemented a notable change in drug policy.

This position paper describes the concerns of some Consortium members at the apparent policy differences emerging between different United Nations agencies, and individual member states, in the run up to the annual meeting of the UN agency responsible for oversight of the global drug control system.